Senior Director, HTA, Value and Evidence, Oncology, Pipeline

HTA, Value And Evidence Oncology Pipeline Senior Director

The HTA, Value and Evidence Oncology Pipeline Senior Director will support the strategic goals of the Oncology Division by driving optimal clinical development strategy and access evidence generation focused on maximizing patient access for oncology assets currently in development. This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust access evidence development relevant to achieve optimal patient access by demonstrating the value of our oncology pipeline. The HTA, Value and Evidence Senior Director will be responsible for independently leading the evidence generation strategy, including execution and dissemination of technical deliverables that support the value of pipeline assets. The HTA, Value and Evidence Senior Director will work closely with cross functional colleagues to ensure robust strategies are in place for optimal HTA submissions and price negotiations. This position will function in a closely aligned fashion with the Oncology and pipeline Global Access & Value (GAV) team members to ensure there is a single and coordinated view on strategy and delivery from the GAV team to the broader Oncology Division.

Role Responsibilities

Lead the development of access evidence generation strategy to support the value of Pfizers Oncology pipeline assets, in close partnership with the cross-functional matrix team.

Lead the coordination of input from local country / regional teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrate the access evidence strategy to support global market access needs at launch and through lifecycle.

Lead the timely development of early launch deliverables including early global value dossiers, value and evidence strategy, integrated evidence plan, systematic literature reviews, early economic models, predictive analytics for value and evidence, and innovative tools to successfully support reimbursement and access requirements in conjunction with the regions / countries.

Lead the design and execution of global HEOR studies (e.g., network meta-analyses, real-world evidence) from concept through publication.

Develop patient-reported outcomes strategy and incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence in line with overall medical strategy for the assets and to ensure global reimbursement and access requirements.

Provide strategic input in the selection of relevant patient population and comparators within clinical trials to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers.

Identify opportunities to partner with external stakeholders to conduct Value and Evidence projects in support of the oncology pipeline assets.

Partner with other GAV cross functional colleagues to ensure strategic alignment and successful / timely execution of projects.

Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community oncology settings to support asset strategies.

Basic Qualifications

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including : the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

Doctorate degree (e.g. PhD, PharmD, DrPH) and 7+ years of experience in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field); Graduate degree (e.g. MPH, MSc) and 10+ years of experience in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field)

Demonstrated in-depth understanding of fundamental health services research methods and tools, including health economic modeling, patient-reported outcomes, statistics, and real-world evidence studies including technical and methodological aspects of registries and observational study design, implementation, analysis and interpretation. Capable of independently managing complex non-interventional study projects.

Knowledge and understanding of drug development process is strongly preferred.

Knowledge and experience in the oncology therapeutic area is preferred.

Experience with HTA organizations such as NICE, CADTH, PBAC, ICER and other HTA groups is desirable.

Excellent interpersonal skills required : ability to understand and respond to multiple internal and external customers.

Excellent oral and written English communication skills required.

Demonstrated ability to assess anticipated value for projects / programs to ensure alignment to business priorities and prioritize accordingly.

An "execution mindset" focused on getting things done quickly and simply.

Strong project management abilities (contracting, budgeting, vendor management) essential. Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities.

Ability to influence key members of medical, clinical, and commercial teams constructively and without conflict.

Skilled in functioning within a matrix organization where managing through influence is required.

Organized and detail oriented with the ability to anticipate needs and to work proactively to prioritize & address / resolve.

Change oriented, comfortable responding to unexpected demands with tight timelines; team player.

Strong understanding of the US healthcare market is desirable.

Other Job Details

Last Date to Apply for Job : November 14th 2025.

Ability to travel based on business needs.

NOT eligible for Relocation Package.

This position is hybrid and requires working onsite 2 to 3 days per week.

The annual base salary for this position ranges from $204,700.00 to $341,100.00. In addition, this position is eligible for participation in Pfizer's Global Performance Plan with a bonus target of 22.5% of the base salary and eligibility to participate in our share based long term incentive program.

We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life's moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver / parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage.